Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xi-Ming Mo"'
Publikováno v:
Innate Immunity, Vol 28 (2022)
Bactericidal/permeability-increasing fold containing family A, member 1 (BPIFA1) is an innate immunity defense protein. Our previous studies proved its antibacterial and antiviral effects, but its role in fungi remains unknown. The study aimed to ide
Externí odkaz:
https://doaj.org/article/66d7f3449040408794980834b2adffbb
Publikováno v:
In Clinical Biochemistry 2009 42(4):420-425
Publikováno v:
Clinical Biochemistry. 53:72-76
Background The current child-specific reference intervals (RIs) are inadequate or even unavailable for many analyses in China. Many of the RIs used in Chinese laboratories were derived from Chinese adult standards or from foreign studies. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d5c1e22eaad65e19b8b83d4c970c62
https://doi.org/10.1016/j.clinbiochem.2018.01.019
https://doi.org/10.1016/j.clinbiochem.2018.01.019
Autor:
Qing-ping Wang, Zhao-Lin Pan, Yu-xi Zhu, Xi-ming Mo, Xuedong Wang, Juan Gu, Zhi-yong Lu, Yu Wang
Publikováno v:
The International Journal of Biochemistry & Cell Biology. 45:2036-2044
Both breast cancer resistance protein (BCRP, ABCG2) and apoptosis-related molecules are involved in the development of multidrug resistance (MDR) in cancer cells. However, the association of BCRP with apoptosis-related molecules in the development of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b197215d00570222255664977cb06e
https://doi.org/10.1016/j.biocel.2013.06.026
https://doi.org/10.1016/j.biocel.2013.06.026
Publikováno v:
Oncology reports. 30(6)
Gastric cancer mainly metastasizes via lymphatic vessels. Thus, it is critical to identify efficacious chemopreventive agents for lymphangiogenesis. The present study was undertaken to explore the effects of rosiglitazone (ROSI) on the growth and lym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f282e007e9eb063df151fc7788b30fd
https://pubmed.ncbi.nlm.nih.gov/24002492
https://pubmed.ncbi.nlm.nih.gov/24002492
Publikováno v:
Clinical biochemistry. 46(12)
Objectives Phenylalanine (Phe) and tyrosine (Tyr) are the most reliable indicators for the diagnosis of phenylketonuria (PKU). The purpose of this study is to establish a simple and rapid method for the determination of Phe and Tyr in peripheral capi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23481a94510a5b6d4a6b968191c0f13
https://pubmed.ncbi.nlm.nih.gov/23711957
https://pubmed.ncbi.nlm.nih.gov/23711957
Publikováno v:
Cell Biology International. 32:S61-S62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f0768ea430d5b5677266755fe491912
https://doi.org/10.1016/j.cellbi.2008.01.263
https://doi.org/10.1016/j.cellbi.2008.01.263
Autor:
Ai Guo Tang, Xi Ming Mo
Publikováno v:
Cell Biology International. 32:S61-S61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2df90f1a36b815c1aa4cb611c6c4ff8d
https://doi.org/10.1016/j.cellbi.2008.01.260
https://doi.org/10.1016/j.cellbi.2008.01.260
Autor:
Hu N; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, 70566The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.; Nan Hu and Xi-Ming Mo contribute equally to the paper., Mo XM; Department of clinical laboratory medicine, 547499The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.; Nan Hu and Xi-Ming Mo contribute equally to the paper., Xu SN; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, 70566The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China., Tang HN; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, 70566The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.; Department of clinical laboratory medicine, 547499The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China., Zhou YH; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, 70566The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China., Li L; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, 70566The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China., Zhou HD; National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, and Department of Metabolism and Endocrinology, 70566The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.
Publikováno v:
Innate immunity [Innate Immun] 2022 Feb; Vol. 28 (2), pp. 67-78. Date of Electronic Publication: 2022 Feb 24.